RE:RE:RE:Last day for tax-loss selling is today! Lol, everybody's talked to Graeme. And then they talk to me. From what I hear, he's only got 5-word cliches for answers about the deal, and nothing about agreement details. It's not his fault. There's no way that DrDR would give him any substantive talking points.
I don't dispute that there is value to Hunter syndrome. Q-Sphera could also be a differentiator for it.
But Bioasis, in the Chiesi deal, valued a single LSD at less than $750,000 up front and less than $35 million in milestone payments.
And Hunter syndrome is touted as the lead program? Come on!
If Bioasis (Graeme, DrDR, pof and fuzzy) think that there's something special about metered (Q-Sphera) delivery, great, but the LSDs, metered or not, aren't worth anything compared to brain tumours, Parkinson's, Alzheimer's, MS, neuroinflammation and a host of other targets that Dr. Deborah Rathjen, Graeme, and Midatech are not discussing with anybody for any reason.
Hunter syndrome. Hoo-rah! You will learn that either Hunter syndrome is worth a lot or that DrDR completely failed to get a proper deal with Chiesi. Can't be both.
jd